Mary W Roederer

607 total citations
22 papers, 458 citations indexed

About

Mary W Roederer is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Computational Theory and Mathematics. According to data from OpenAlex, Mary W Roederer has authored 22 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Pediatrics, Perinatology and Child Health and 4 papers in Computational Theory and Mathematics. Recurrent topics in Mary W Roederer's work include Pharmacogenetics and Drug Metabolism (13 papers), Pharmaceutical studies and practices (9 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Mary W Roederer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Pharmaceutical studies and practices (9 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Mary W Roederer collaborates with scholars based in United States, China and Ghana. Mary W Roederer's co-authors include Howard L. McLeod, Shanna K. O’Connor, Stefanie P. Ferreri, Anthony J. Viera, Hawazin Faruki, George J. Knafl, Márcia Van Riper, John Valgus, Wei Zhang and Kristin Weitzel and has published in prestigious journals such as PLoS ONE, Bulletin of the World Health Organization and Annals of Pharmacotherapy.

In The Last Decade

Mary W Roederer

19 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary W Roederer United States 13 272 180 102 76 60 22 458
Jivan Moaddeb United States 14 277 1.0× 174 1.0× 103 1.0× 86 1.1× 67 1.1× 21 461
Gillian C. Bell United States 13 398 1.5× 249 1.4× 55 0.5× 120 1.6× 96 1.6× 23 735
Natasha Petry United States 11 202 0.7× 111 0.6× 50 0.5× 98 1.3× 78 1.3× 42 437
Otito F. Iwuchukwu United States 11 218 0.8× 91 0.5× 62 0.6× 63 0.8× 33 0.6× 31 566
Arthur F. Harralson United States 14 180 0.7× 94 0.5× 61 0.6× 105 1.4× 134 2.2× 31 525
Kristine Ashcraft United States 7 210 0.8× 136 0.8× 83 0.8× 57 0.8× 23 0.4× 11 315
Narith N. Ou United States 11 186 0.7× 105 0.6× 72 0.7× 71 0.9× 43 0.7× 23 465
Katja S. Just Germany 13 149 0.5× 113 0.6× 103 1.0× 107 1.4× 29 0.5× 40 663
Carolyn R. Rohrer Vitek United States 12 267 1.0× 158 0.9× 36 0.4× 109 1.4× 85 1.4× 17 398
Dyson T. Wake United States 8 241 0.9× 165 0.9× 31 0.3× 61 0.8× 74 1.2× 13 358

Countries citing papers authored by Mary W Roederer

Since Specialization
Citations

This map shows the geographic impact of Mary W Roederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary W Roederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary W Roederer more than expected).

Fields of papers citing papers by Mary W Roederer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary W Roederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary W Roederer. The network helps show where Mary W Roederer may publish in the future.

Co-authorship network of co-authors of Mary W Roederer

This figure shows the co-authorship network connecting the top 25 collaborators of Mary W Roederer. A scholar is included among the top collaborators of Mary W Roederer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary W Roederer. Mary W Roederer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juliano, Jonathan J., Howard L. McLeod, & Mary W Roederer. (2020). Can pharmacogenomics improve malaria drug policy?. UNC Libraries.
2.
Roederer, Mary W, Grace m. Kuo, David F. Kisor, et al.. (2016). Pharmacogenomics competencies in pharmacy practice: A blueprint for change. Journal of the American Pharmacists Association. 57(1). 120–125. 52 indexed citations
3.
Roederer, Mary W, et al.. (2015). Fast And Frugal Trees: Translating Population-Based Pharmacogenomics to Medication Prioritization. Personalized Medicine. 12(2). 117–128. 5 indexed citations
4.
Vaughan, K.T. L., et al.. (2014). An evaluation of pharmacogenomic information provided by five common drug information resources. Journal of the Medical Library Association JMLA. 102(1). 47–51. 11 indexed citations
5.
Ferreri, Stefanie P., Shanna K. O’Connor, Anthony J. Viera, et al.. (2014). Implementation of a pharmacogenomics service in a community pharmacy. Journal of the American Pharmacists Association. 54(2). 172–180. 73 indexed citations
6.
Shu, Yan, Qing Li, Linyong Xu, et al.. (2013). Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan. PLoS ONE. 8(8). e70341–e70341. 12 indexed citations
7.
8.
Roederer, Mary W, Macary Weck Marciniak, Shanna K. O’Connor, & Stephen F Eckel. (2013). An integrated approach to research and manuscript development. American Journal of Health-System Pharmacy. 70(14). 1211–1218. 3 indexed citations
9.
Murray, Brian, et al.. (2013). Genes and Beans: Pharmacogenomics of Renal Transplant. Pharmacogenomics. 14(7). 769–781. 13 indexed citations
10.
Roederer, Mary W. (2012). NAVAGATE: A Rubric to Move from Pharmacogenomics Science to Pharmacogenomics Practice. Pharmacogenomics. 13(11). 1307–1313. 3 indexed citations
11.
O’Connor, Shanna K., Stefanie P. Ferreri, Anthony J. Viera, et al.. (2012). Making pharmacogenetic testing a reality in a community pharmacy. Journal of the American Pharmacists Association. 52(6). e259–e265. 31 indexed citations
12.
O’Connor, Shanna K., Stefanie P. Ferreri, Anthony J. Viera, et al.. (2012). Exploratory Planning and Implementation of a Pilot Pharmacogenetic Program in a Community Pharmacy. Pharmacogenomics. 13(8). 955–962. 28 indexed citations
13.
Zhang, Wei, et al.. (2012). Pharmacogenetics of Drugs Withdrawn from the Market. Pharmacogenomics. 13(2). 223–231. 32 indexed citations
14.
Roederer, Mary W, et al.. (2011). Can pharmacogenomics improve malaria drug policy?. Bulletin of the World Health Organization. 89(11). 838–845. 18 indexed citations
15.
O’Connor, Shanna K., et al.. (2011). Pharmacogenomics in a community pharmacy: ACT now. Journal of the American Pharmacists Association. 51(2). 189–193. 30 indexed citations
16.
Roederer, Mary W, et al.. (2011). Global Formulary Review: How Do We Integrate Pharmacogenomic Information?. Annals of Pharmacotherapy. 45(4). 532–538.
17.
Roederer, Mary W, Márcia Van Riper, John Valgus, George J. Knafl, & Howard L. McLeod. (2011). Knowledge, Attitudes and Education of Pharmacists Regarding Pharmacogenetic Testing. Personalized Medicine. 9(1). 19–27. 67 indexed citations
18.
Roederer, Mary W & Howard L. McLeod. (2010). Applying the Genome to National Drug Formulary Policy in the Developing World. Pharmacogenomics. 11(5). 633–636. 14 indexed citations
19.
Roederer, Mary W. (2009). Cytochrome P450 enzymes and genotype-guided drug therapy.. PubMed. 11(6). 632–40. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jivan Moaddeb Breakdown of academic impact, for papers by Gillian C. Bell Breakdown of academic impact, for papers by Natasha Petry Breakdown of academic impact, for papers by Otito F. Iwuchukwu Breakdown of academic impact, for papers by Arthur F. Harralson Breakdown of academic impact, for papers by Kristine Ashcraft Breakdown of academic impact, for papers by Narith N. Ou Breakdown of academic impact, for papers by Katja S. Just Breakdown of academic impact, for papers by Carolyn R. Rohrer Vitek Breakdown of academic impact, for papers by Dyson T. Wake
Rankless by CCL
2026